首页> 外文期刊>American Journal of Dermatopathology >Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study.
【24h】

Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study.

机译:常见痣,发育不良痣和原发性恶性黑色素瘤中受体酪氨酸激酶erbB家族表达的不同模式:一项免疫组织化学研究。

获取原文
获取原文并翻译 | 示例
           

摘要

erbB receptors contribute to tumor formation and progression. Variable expression of erbB1, erbB2, and erbB3 has been reported in nevi and melanomas; erbB4 has hardly been investigated. We examined the expression of all 4 erbB receptors in common and dysplastic nevi and melanomas. Formalin-fixed, paraffin-embedded tissues of 100 melanomas, 27 common nevi, and 23 dysplastic nevi were immunostained with antibodies against the 4 erbB receptors. erbB3 and erbB4 showed stronger positivity in nevi than in melanomas, and in common than in dysplastic nevi. Staining pattern was more orderly in nevi than in melanomas. Common nevi showed more prominent membranous staining for erbB3 than dysplastic nevi followed by melanomas. In melanomas, greater thickness was associated with more widespread erbB2 and erbB3 staining in the vertical than in the radial growth phase, and in the dermal than in the epidermal component. Higher mitotic counts were associated with more widespread and intense erbB2 expression in the vertical growth phase than in the radial growth phase and in the dermal than in the epidermal component. Melanomas with more widespread erbB2 staining had heavier lymphocytic infiltrates. erbB1 expression was negligible in all groups. erbB2, erbB3, and erbB4 are expressed in all subtypes of melanocytic lesions, but with quantitative and qualitative differences. Receptor expression seems to decrease and to become less mature and orderly with tumor progression. The complex patterns of erbB receptor expression in melanocytic lesions warrant further investigation.
机译:erbB受体有助于肿瘤的形成和发展。 erbB1,erbB2和erbB3的可变表达在痣和黑色素瘤中已有报道。 erbB4几乎没有被研究过。我们检查了所有4种erbB受体在常见和发育不良的痣和黑色素瘤中的表达。用针对4个erbB受体的抗体对100个黑色素瘤,27个常见痣和23个增生异常痣的福尔马林固定,石蜡包埋的组织进行免疫染色。 erbB3和erbB4在痣中的阳性率比在黑色素瘤中强,并且在正常情况下比增生性痣中的阳性率更高。与黑色素瘤相比,痣的染色模式更为有序。普通痣显示的erbB3膜染色比增生性痣和黑色素瘤更为突出。在黑色素瘤中,更大的厚度与垂直的比径向生长期的erbB2和erbB3染色有关,而真皮的比表皮成分更广泛。在垂直生长期比在径向生长期和在真皮中比在表皮成分中,更高的有丝分裂计数与更广泛和更强烈的erbB2表达有关。 erbB2染色较广泛的黑色素瘤具有较重的淋巴细胞浸润。 erbB1表达在所有组中均可以忽略不计。 erbB2,erbB3和erbB4在黑素细胞病变的所有亚型中都有表达,但在数量和质量上存在差异。受体表达似乎随着肿瘤进展而降低并且变得不那么成熟和有序。黑色素细胞病变中erbB受体表达的复杂模式值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号